Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Novel Treatment Option in Advanced Soft Tissue Sarcomas

DSpace Repository

Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Novel Treatment Option in Advanced Soft Tissue Sarcomas

Author: Hagelstein, Ilona; Lutz, Martina S.; Schmidt, Moritz; Heitmann, Jonas S.; Malenke, Elke; Zhou, Yanjun; Clar, Kim L.; Kopp, Hans-Georg; Jung, Gundram; Salih, Helmut R.; Maerklin, Melanie; Hinterleitner, Clemens
Tübinger Autor(en):
Hagelstein, Ilona
Lutz, Martina S.
Schmidt, Moritz
Heitmann, Jonas S.
Malenke, Elke
Zhou, Yanjun
Clar, Kim L.
Kopp, Hans-Georg
Jung, Gundram
Hinterleitner, Clemens
Salih, Helmut R.
Märklin, Melanie
Published in: Frontiers in Immunology (2021), Bd. 12, Article 653081
Verlagsangabe: Frontiers Media Sa
Language: English
Full text: http://dx.doi.org/10.3389/fimmu.2021.653081
ISSN: 1664-3224
DDC Classifikation: 570 - Life sciences; biology
610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)